Omid Abdolazimi, Mitra Salehi Esfandarani, Maryam Salehi, Davood Shishebori and Majid Shakhsi-Niaei
This study evaluated the influence of the coronavirus pandemic on the healthcare and non-cold pharmaceutical care distribution supply chain.
Abstract
Purpose
This study evaluated the influence of the coronavirus pandemic on the healthcare and non-cold pharmaceutical care distribution supply chain.
Design/methodology/approach
The model involves four objective functions to minimize the total costs, environmental impacts, lead time and the probability of a healthcare provider being infected by a sick person was developed. An improved version of the augmented e-constraint method was applied to solve the proposed model for a case study of a distribution company to show the effectiveness of the proposed model. A sensitivity analysis was conducted to identify the sensitive parameters. Finally, two robust models were developed to overcome the innate uncertainty of sensitive parameters.
Findings
The result demonstrated a significant reduction in total costs, environmental impacts, lead time and probability of a healthcare worker being infected from a sick person by 40%, 30%, 75% and 54%, respectively, under the coronavirus pandemic compared to the normal condition. It should be noted that decreasing lead time and disease infection rate could reduce mortality and promote the model's effectiveness.
Practical implications
Implementing this model could assist the healthcare and pharmaceutical distributors to make more informed decisions to minimize the cost, lead time, environmental impacts and enhance their supply chain resiliency.
Originality/value
This study introduced an objective function to consider the coronavirus infection rates among the healthcare workers impacted by the pharmaceutical/healthcare products supply chain. This study considered both economic and environmental consequences caused by the coronavirus pandemic condition, which occurred on a significantly larger scale than past pandemic and epidemic crises.
Details
Keywords
Davood Shishebori and Ali Zeinal Hamadani
The aim of this paper is to consider the effect of gauge measurement capability on the multivariate process capability index (MCp).
Abstract
Purpose
The aim of this paper is to consider the effect of gauge measurement capability on the multivariate process capability index (MCp).
Design/methodology/approach
With respect to measurement capability, the paper investigates the statistical properties of the estimated MCp and considers the effect of gauge measurement capability on the lower confidence bound, hypothesis testing, critical value and power of testing for MCp at the mentioned state.
Findings
The results show that gauge measurement capabilities will notably change the results of estimating and testing the process capability index.
Originality/value
The research would help quality experts to determine whether their processes meet the required capability, and to make more reliable decisions.